FDA
-
-
-
-
-
-
-
Organon's VTAMA cream gets strong recommendation in pediatric dermatitis guidelines
-
-
-
-
-
-
-
Organon Enters into Agreement to License MIUDELLA®, Sebela Pharmaceuticals’ Hormone-Free Intrauterine Device
-
-
-
-
-
-
-
Organon Reports Results for the Third Quarter Ended September 30, 2025
-
-
-
-
-
-
-
organon's (OGN) VTAMA cream receives strong recommendation from dermatology academy
-
-
-
-
-
-
-
European Medicines Agency (EMA) Validates Henlius and Organon Filing for Perjeta® (pertuzumab) Biosimilar Candidate HLX11
-
-
-
-
-
-
-
Update on FDA Review of VTAMA® (tapinarof) Cream, 1% for the Treatment of Atopic Dermatitis in Adults and Children 2 Years of Age and Older
-
-
-
-
-
-
-
Organon to Acquire Dermavant including its Innovative Dermatologic Therapy, VTAMA® (tapinarof) Cream, 1%
-
323,438 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

